Report Scope:
The scope of this study encompasses an investigation of the market's cell and gene therapy tools such as GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. This research analyzes each tool type, determines its current market status, examines its impact on future markets, and presents forecasts of growth over the next five years. Technological issues, including the latest trends, are discussed. The publisher analyzes the industry on a worldwide basis, from both application and demand perspectives, in the major regions of the world.
Report Includes:
- 77 data tables
- An overview of the global market for immunoassay-based cell and gene therapy tools, and reagents within the life sciences industry
- Analyses of the global market trends, with data corresponding to market size for 2017-2019, and projections of compound annual growth rates (CAGRs) through 2024
- Information about in-vitro diagnostics (IVD), its background and importance of IVD testing
- Discussion on the prevalence of the infectious disease, metabolic disorders and chronic ailments as drivers of immunoassay testing market
- Description of recent technologies such as chemiluminescent immunoassays (CLIA), fluorescent immunoassays, multiplex assays, and rapid diagnostic technologies
- Evaluation of the market potential for immunoassay-based cell and gene therapy tools and reagents, current market size and market forecast, and market share analysis of the leading players engaged
- Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
- Company profiles of the key market participants, including Bio-Rad Laboratories, Cytiva Life Sciences, Luminex Corp., Millipore Sigma, Thermo Fisher Scientific and STEMCELL Technologies
Table of Contents
Samples
LOADING...
Executive Summary
Reasons for Doing this Study:
Gene and cell therapy are emerging as important tools to treat human health. Techniques such as CAR-T therapy have emerged as key ways of treating many different types of cancers. The promise of gene therapy using technologies such as CRISPR is starting to be realized in clinical trials, and markets are scaling up to treat other diseases as well, particularly rare gene-based diseases. As these therapies are coming to the fore, a new market for tools to develop these therapies using standard methodologies is emerging. This report will cover what those tools are, how they impact the larger life science tools market, and how they will evolve over the next five years.
Companies Mentioned
- Abcam
- Adverum Biotechnologies
- Athersys Inc.
- Avrobio
- Bio-Rad Laboratories
- Bio-Techne
- Cellgenix
- Cytiva Life Sciences
- Luminex Corp.
- Mesoblast Ltd.
- Millipore Sigma
- Miltenyi Biotec
- Organicell
- Quanterix
- Sartorius
- Stemcell Technologies
- Thermo Fisher
Related Reports
Gene Therapy-Competitive landscape, 2023
- Report
- 450 Pages
- Global
Cell & Gene Therapy Manufacturing Services Global Market Report 2024
- Report
- 200 Pages
- Global
Global Cell and Gene Therapy Market
- Report
- 145 Pages
- Global
Cell and Gene Therapy Manufacturing Services Market
- Report
- 138 Pages
- Global
